Back to mobile site

More on CRVS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-50.0% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (8/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Corvus Pharma (NQ:CRVS)
Delayed: 11.91 -0.09 (0.75%)
Prev. Close $12.00  
Open$12.36 
52 Wk High$17.77 
52 Wk Low$9.63 
Day High$12.58 
Day Low$11.73 
P/E N/A  
EPS$0.00 
Volume1,977,182 

Friends, Peers and Foes (?): GILD, REGN, 1ZLB, DNA, EXEL (more...)

Jun 15, 2026 05:12 PM Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Moore David Scott
Jun 15, 2026 05:10 PM Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: CLARK IAN T
Jun 15, 2026 05:08 PM Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Grais Linda
Jun 15, 2026 05:07 PM Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Thompson Peter A.
Jun 15, 2026 05:04 PM Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: van den Broek Richard
Jun 12, 2026 04:01 PM Form 8-K Corvus Pharmaceuticals, For: Jun 11
Jun 9, 2026 07:30 AM Corvus Pharmaceuticals invests $5 million in Angel Pharmaceuticals
Jun 9, 2026 07:30 AM Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
May 20, 2026 04:12 PM Form 4 Corvus Pharmaceuticals, For: May 18 Filed by: MILLER RICHARD A MD
May 20, 2026 04:01 PM Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
View All Articles

Entities mentioned with CRVS

View All Entities